Bullock, Laurna http://orcid.org/0000-0002-4193-1835
Manning, Fay http://orcid.org/0000-0002-9768-1695
Hawarden, Ashley http://orcid.org/0000-0002-5462-579X
Fleming, Jane
Leyland, Sarah
Clark, Emma M.
Thomas, Simon
Gidlow, Christopher
Iglesias-Urrutia, Cynthia P.
Protheroe, Joanne http://orcid.org/0000-0002-9608-1487
Lefroy, Janet http://orcid.org/0000-0002-2662-1919
Ryan, Sarah
O’Neill, Terence W.
Mallen, Christian
Jinks, Clare http://orcid.org/0000-0002-3407-2446
Paskins, Zoe http://orcid.org/0000-0002-7783-2986
Funding for this research was provided by:
National Institute for Health and Care Research (CS-2018-18-ST2-010)
Royal Osteoporosis Society (430)
Haywood Foundation
Article History
Received: 5 January 2024
Accepted: 29 May 2024
First Online: 19 June 2024
Declarations
:
: Ethical permission for the study was given by North West-Greater Manchester West Research Ethics Committee (reference number: 19/NW/0559).
: Informed consent was obtained from all individual participants included in the study.
: Professor Zoe Paskins has received consultancy fees from UCB for a non-promotional advisory board. Keele University has received sponsorship from UCB Pharma. Dr Laurna Bullock, Dr Fay Manning, Dr Ashley Hawarden, Dr Jane Fleming, Sarah Leyland, Prof Emma M Clark, Simon Thomas, Prof Christopher Gidlow, Prof Cynthia P Iglesias-Urrutia, Prof Joanne Protheroe, Prof Janet Lefroy, Prof Sarah Ryan, Prof Terence W O’Neill, Prof Christian Mallen and Prof Clare Jinks declare that they have no conflict of interest. This study presents independent research funded by the NIHR. The views expressed are those of the author(s) and not necessarily those of the National Health Service, the NIHR, or the Department of Health and Social Care.